company background image
A238120 logo

Aligned Genetics KOSDAQ:A238120 Stock Report

Last Price

₩3.69k

Market Cap

₩40.8b

7D

29.8%

1Y

-6.4%

Updated

20 Nov, 2024

Data

Company Financials

Aligned Genetics, Inc.

KOSDAQ:A238120 Stock Report

Market Cap: ₩40.8b

A238120 Stock Overview

A biotech company, develops, manufactures, and sells imaging solutions for research institutions worldwide. More details

A238120 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends0/6

Rewards

Earnings grew by 51.5% over the past year

Risk Analysis

Does not have a meaningful market cap (₩41B)


Aligned Genetics, Inc. Competitors

WOOJUNG BIO

KOSDAQ:A215380

₩32.3b

C&R Research

KOSDAQ:A359090

₩64.4b

P&K Skin Research Center

KOSDAQ:A347740

₩60.7b

Celemics

KOSDAQ:A331920

₩28.6b

Price History & Performance

Summary of all time highs, changes and price drops for Aligned Genetics
Historical stock prices
Current Share Price₩3,685.00
52 Week High₩4,640.00
52 Week Low₩2,750.00
Beta0.29
11 Month Change23.45%
3 Month Change7.91%
1 Year Change-6.35%
33 Year Change-14.30%
5 Year Change0.96%
Change since IPO-30.96%

Recent News & Updates

Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

Aug 12
Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

Recent updates

Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

Aug 12
Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Apr 06
If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

Feb 11
Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

Shareholder Returns

A238120KR Life SciencesKR Market
7D29.8%-7.6%-0.7%
1Y-6.4%32.0%-4.1%

Return vs Industry: A238120 underperformed the KR Life Sciences industry which returned 32% over the past year.

Return vs Market: A238120 underperformed the KR Market which returned -4.1% over the past year.

Price Volatility

Is A238120's price volatile compared to industry and market?
A238120 volatility
A238120 Average Weekly Movement3.5%
Life Sciences Industry Average Movement8.7%
Market Average Movement5.6%
10% most volatile stocks in KR Market11.5%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A238120 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A238120's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200865Yeon-Cheol Jungalignedgenetics.com

Aligned Genetics, Inc., a biotech company, develops, manufactures, and sells imaging solutions for research institutions worldwide. The company offers solutions for digital cell imaging, and tissue clearing and 3D imaging. It offers its solutions through distributors.

Aligned Genetics, Inc. Fundamentals Summary

How do Aligned Genetics's earnings and revenue compare to its market cap?
A238120 fundamental statistics
Market cap₩40.76b
Earnings (TTM)₩3.31b
Revenue (TTM)₩14.93b

16.0x

P/E Ratio

3.5x

P/S Ratio

Is A238120 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A238120 income statement (TTM)
Revenue₩14.93b
Cost of Revenue₩4.32b
Gross Profit₩10.61b
Other Expenses₩7.29b
Earnings₩3.31b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)230.54
Gross Margin71.05%
Net Profit Margin22.20%
Debt/Equity Ratio11.9%

How did A238120 perform over the long term?

See historical performance and comparison